RxDoctor Payments Data

Larry Gambrell, DO

Otolaryngology/Facial Plastic Surgery · Sebastopol, CANPI 1275621963

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Sanofi at 29.4% of the total. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in CA, where the typical reported total is $1,073.

$1,073in general payments, 2019–2025

Across 36 payments — averaging $29.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$315
  • Stryker$221
  • Aerin Medical Inc.$210
  • GSK$70
  • Medtronic$42
  • KARL Storz Endoscopy-america$32
  • plus $182 from 8 others

What the payments were for

  • Food & beverage$1,073100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,073 in reported general payments places this provider in the 50th percentile of 102 otolaryngology/facial plastic surgery providers in California.

See all otolaryngology/facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$69,031
Medicare patients
300
Services billed
1,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide106$2,367
Azelastine Hcl19$608
Ofloxacin13$405
Montelukast Sodium21$278
Triamcinolone Acetonide11$222
Fluticasone Propionate20$194
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$192
Omeprazole18$141
Prednisone55$117
Famotidine12$55
Azithromycin11$47

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Sebastopol

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →